Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The overall aim of the study is to investigate the Ponto wide implant considering; initial implant stability, stability over time, skin reaction and long term success when loaded at 3 weeks post surgery. Patients' quality of life improvements following implantation will also be surveyed.
More specifically the primary objective of this clinical study is to test the hypothesis
And the secondary objective is to
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Wide diameter implant | Other | Bone anchored hearing implant For the wide diameter arm (test group), the Ponto wide implant (diameter 4,5mm, length 4mm) and abutment 6mm developed by Oticon Medical AB (Gothenburg, Sweden) will be installed. |
|
| Control group | Other | Bone anchored hearing implant For the control group, the previous generation Ponto implant (diameter 3,75mm, length 4mm) and 6mm abutment (Oticon Medical AB, Gothenburg, Sweden) will be installed. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bone anchored hearing implant | Device |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| ISQ (Implant Stability Quotient) | ISQ (implant Stability Quotient) is a measurement scale for use with the Resonance Frequency Analysis (RFA) method of determining implant stability. The measurement is made using the Osstell Mentor equipment (Osstell, Sweden) with SmartPegs. ISQ values range from 1 to 100, the higher the score the higher the stability. The highest and lowest score obtained from perpendicular measurements will be registered. | Surgery (0 days) |
| ISQ (Implant Stability Quotient) | 7 days after surgery | |
| ISQ (Implant Stability Quotient) | 14 days after surgery | |
| ISQ (Implant Stability Quotient) | 21 days after surgery | |
| ISQ (Implant Stability Quotient) | 28 days after surgery | |
| ISQ (Implant Stability Quotient) | 6 weeks after surgery | |
| ISQ (Implant Stability Quotient) | 12 weeks after surgery | |
| ISQ (Implant Stability Quotient) | 6 months after surgery | |
| ISQ (Implant Stability Quotient) | 12 months after surgery | |
| ISQ (Implant Stability Quotient) |
| Measure | Description | Time Frame |
|---|---|---|
| Time of minimum ISQ (Implant stability quotient) | Implant stability can be seen as a combination of mechanical stability, which is the result of compressed bone holding the implant tightly in place, and biological stability, which is the result of new bone forming at the site of implantation and osseointegration. Mechanical stability is generally high immediately after implant placement and is decreasing with time. Biological stability, on the other hand, is non-existent immediately after placement and increases with time. The final stability level for an implant is the sum of the two. There is likely to be an initial decrease in stability followed by a subsequent increase as the implant becomes biologically stable. ISQ (implant Stability Quotient) is a measurement scale for use with the Resonance Frequency Analysis (RFA) method of determining implant stability. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Myrthe KS Hol, MD, PhD | University Medical Center St Radboud, Nijmegen, The Netherlands | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Medical Center St Radboud | Nijmegen | 6500 | Netherlands |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25790770 | Result | Nelissen RC, den Besten CA, Mylanus EA, Hol MK. Stability, survival, and tolerability of a 4.5-mm-wide bone-anchored hearing implant: 6-month data from a randomized controlled clinical trial. Eur Arch Otorhinolaryngol. 2016 Jan;273(1):105-11. doi: 10.1007/s00405-015-3593-x. Epub 2015 Mar 20. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003638 | Deafness |
| D034381 | Hearing Loss |
| D006314 | Hearing Loss, Conductive |
| D006311 | Hearing Disorders |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| ID | Term |
|---|---|
| D012678 | Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 24 months after surgery |
| ISQ (Implant Stability Quotient) | 36 months after surgery |
| 0, 7, 14, 21 and 28 days after surgery |
| ISQ (Implant stability quotient) gradient | ISQ (implant stability quotient) per time unit gives a measure of osseointegration speed. | 0, 7, 14, 21 and 28 days, 6 weeks, 12weeks, 6 months after surgery |
| Skin condition according to Holgers score | Holgers score is a standardized scale to clinically assess skin condition around a percutaneous implant | 7 days after surgery |
| Skin condition according to Holgers score | 14 days after surgery |
| Skin condition according to Holgers score | 21 days after surgery |
| Skin condition according to Holgers score | 28 days after surgery |
| Skin condition according to Holgers score | 6 weeks after surgery |
| Skin condition according to Holgers score | 12 weeks after surgery |
| Skin condition according to Holgers score | 6 months after surgery |
| Skin condition according to Holgers score | 12 months after surgery |
| Skin condition according to Holgers score | 24 months after surgery |
| Skin condition according to Holgers score | 36 months after surgery |
| Glasgow Benefit Inventory Questionnaire | Glasgow Benefit Inventory Questionnaire (GBI) 18-item, post-surgical questionnaire given to patients. The GBI measures the change in health status produced by surgical interventions (here, "health status" is the general perception of well-being, including total psychological, social, and physical well being). | 3 months after surgery |
| Glasgow Benefit Inventory Questionnaire | 12 months after surgery |
| Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire | The APHAB is a 24-item self-assessment inventory in which patients report the amount of trouble they are having with communication or noises in various everyday situations. Benefit is calculated by comparing the patient's reported difficulty in the unaided condition with their amount of difficulty when using amplification. The APHAB produces scores for 4 subscales: Ease of Communication (EC), Reverberation (RV), Background Noise (BN), and Aversiveness (AV). | Before surgery |
| Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire | 6 months after surgery |
| Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire | 36 months after surgery |
| Glasgow Health Status Inventory (GHSI) questionnaire | The Glasgow Health Status Inventory is an 18 item questionnaire. It assesses health state, by measuring the effect of a health problem on the quality of life of a person. It allows cross-comparison among many health conditions, among different health interventions, and among demographic and cultural subgroups. | Before surgery |
| Glasgow Health Status Inventory (GHSI) questionnaire | 6 months after surgery |
| Glasgow Health Status Inventory (GHSI) questionnaire | 36 months after surgery |
| D013568 | Pathological Conditions, Signs and Symptoms |